New Key Statistics Module, Z-Score and F-Score
SZSE:300194 Key Ratios
Market Cap ¥ M | 4,639.88 |
Enterprise Value ¥ M | 4,415.46 |
P/E(ttm) | 17.73 |
PE Ratio without NRI | 16.88 |
Forward PE Ratio | -- |
Price/Book | 1.09 |
Price/Sales | 1.71 |
Price/Free Cash Flow | 14.46 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.22 |
Revenue (TTM) ¥ M | 2,766.00 |
EPS (TTM) ¥ | 0.22 |
Beneish M-Score | -2.6 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 31.70 |
EV-to-EBIT | 12.09 |
EV-to-EBITDA | 12.09 |
PEG | -- |
Shares Outstanding M | 1,189.71 |
Net Margin (%) | 9.70 |
Operating Margin % | 9.96 |
Pre-tax Margin (%) | 12.07 |
Quick Ratio | 1.22 |
Current Ratio | 1.77 |
ROA % (ttm) | 4.36 |
ROE % (ttm) | 6.49 |
ROIC % (ttm) | 4.87 |
Dividend Yield % | 1.28 |
Altman Z-Score | 2.77 |
SZSE:300194 Number of Guru Trades
SZSE:300194 Volume of Guru Trades
Gurus Latest Trades with SZSE:300194
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300194 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Fuan Pharmaceutical (Group) Co Ltd Insider Transactions
No Available Data